Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Clin Pharmacol Ther. 2022 Dec 8;113(3):680–691. doi: 10.1002/cpt.2787

Table 2.

Local Ancestry at CYP2C9 and VKORC1

Gene Copiesa Tucson, AZ (n = 141) San Juan, PR (n = 96) Total (n = 237) P-valueb
CYP2C9 EUR < 0.001
0 28 (20.3%) 8 (8.4%) 36 (15.5%)
1 55 (39.9%) 23 (24.2%) 78 (33.5%)
2 55 (39.9%) 64 (67.4%) 119 (51.1%)
AMR < 0.001
0 58 (42.0%) 87 (91.6%) 145 (62.2%)
1 56 (40.6%) 6 (6.3%) 62 (26.6%)
2 24 (17.4%) 2 (2.1%) 26 (11.2%)
AFR < 0.001
0 131 (94.9%) 70 (73.7%) 201 (86.3%)
1 7 (5.1%) 21 (22.1%) 28 (12.0%)
2 0 (0.0%) 4 (4.2%) 4 (1.7%)
VKORC1 EUR < 0.001
0 23 (17.3%) 4 (4.4%) 27 (12.1%)
1 54 (40.6%) 21 (23.1%) 75 (33.5%)
2 56 (42.1%) 66 (72.5%) 122 (54.5%)
AMR < 0.001
0 59 (44.4%) 88 (96.7%) 147 (65.6%)
1 52 (39.1%) 3 (3.3%) 55 (24.6%)
2 22 (16.5%) 0 (0.0%) 22 (9.8%)
AFR < 0.001
0 129 (97.0%) 69 (75.8%) 198 (88.4%)
1 4 (3.0%) 18 (19.8%) 22 (9.8%)
2 0 (0.0%) 4 (4.4%) 4 (1.8%)
a

Copies indicates the haploid count of ancestrally similar segments at a given gene and copies are denoted for each ancestral reference used

b

Hypotheses were tested with chi-square goodness of fit test for equal counts per cohort with tableby() from the arsenal package in R

AZ indicates Arizona; PR, Puerto Rico; CYP2C9, Cytochrome P450 family 2 subfamily C member 9; VKORC1, Vitamin K epoxide Reductase Complex subunit 1; EUR, Europeans of the Iberian Peninsula and Spain; AMR, Indigenous American (multiple ethnic groups); AFR, Africans of Yorubaland